Note: The testimony presented here consists of witnesses' prepared statements and are not official transcripts of the proceedings.

Accutane - Is this Drug Treatment Linked to Depression and Suicide? 106 th Congress (1999-2000) December 5, 2000 1:00 p.m. Rayburn House Office Building Chairman Burton's Opening Statement WITNESS LIST Panel I The Family Perspective Lori and Amanda Callais Denham Springs, Louisiana Stacy and Mike Baumann Mundelein, Illinois Charles H. Jackson, Jr. Lubbock, Texas Panel II David M. Pariser, MD, FACP American Academy of Dermatology Pariser Dermatology Specialist, Ltd. Virginia Clinical Research, Inc. Norfolk, Virginia Douglas Jacobs, MD Roche Consultant Associate Clinical Professor of Psychiatry Harvard Medical School Wellesley, Massachusetts  James T. O'Donnel, PharmD., M.S. Assistant Professor of Pharmacology Rush Medical School Pallentine, Illinois Dr. Jonca Bull Food and Drug Administration Accompanied by Dr. Phyllis Huene

If you or someone you know has had complications after taking Accutane contact us for immediate evaluation of your situation.

Free Legal Consultation | Accutane Facts | Depression and Suicide
New FDA Warnings | Congressional Hearing | Submit a Case | Home

If you need immediate attention please call 1-800-942-2056

Accutane Suicide Help Line is a public advocacy group located at
One Boston Place, Suite 3615
Boston, MA 02108
Partners and Affiliates throughout the US
This site is not authorized by Roche Pharmaceuticals: the manufacturers of Accutane and is not an Official Site of Accutane

Use of this site is dictated by our terms and conditions